This drug is a small molecule inhibitor of 3CLpro, a conserved protease in all known coronaviruses that plays a crucial role in proteolytic processing of the replicase polyproteins. The drug aims to inhibit 3CLpro, blocking SARS-CoV-2 replication and potentially treating multiple strains of COVID-19 and other coronaviruses.
×
Insilico Medicine � 3CLpro Inhibitor (COVID-19 treatment
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD